It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
originally posted by: Xtrozero
At the end of the day States that have legalized it will going on, many other States will legalized it and in the near future it will be taken off the schedule 1 list...
Another I hate Trump posting, but then 8 years under Obama and nothing. Even towards the end of his 8 years we got this..
The Obama administration has denied a bid by two Democratic governors to reconsider how it treats marijuana under federal drug control laws, keeping the drug for now, at least, in the most restrictive category for U.S. law enforcement purposes.
I really do not want to do the "what did Obama do" but come on people....
originally posted by: mOjOm
a reply to: seeker1963
That's a valid position to have. In which case you should be upset that they are going out of their way and wasting their time going after MJ instead of working on those other issues.
Nobody is looking into solving those issues when they're occupied with coming up with ways to start making MJ users into crinimals.
They will in effect be killing jobs and spending money on destroying something that was actually creating jobs and making money. Just the opposite of what you want to happen.
I'd say that makes this a priority. After all, what other new industry can you think of that has made such record profits and created so many new jobs other than Legalized MJ???
originally posted by: dreamingawake
Under Obama states started to legalize. Obama didn't care to support it but left it alone. Trump he wants to turn around everything Obama has done.
originally posted by: HappyFisherman
Meanwhile there is a opoid epidemic, something this Sessions fool should be concentrating on. But no this fool is locked in the Nixon era. Great choice Trump! Trump fire this fool Please!
Big Pharma tends to spend more on Republicans than Democrats, and the GOP benefited from 58 percent of the industry's federal contributions in 2012 and 2014 while Democrats received 42 percent, according to the CRP.
Perhaps unsurprisingly, it's a group of 18 House Democrats, not Republicans, who are demanding that the CEO of Valeant Pharmaceuticals, Michael Pearson, join Shkreli in front of the House Oversight Committee during the first week of October to answer questions about recent price hikes on two drugs produced by his company.